ZVRA
Zevra Therapeutics Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$766.72M
P/E Ratio
6.45
EPS
$2.01
Beta
0.89
52W High
$14.27
52W Low
$7.16
50-Day MA
$10.64
200-Day MA
$9.51
Dividend Yield
—
Profit Margin
101.60%
Forward P/E
12.61
PEG Ratio
10.67
About Zevra Therapeutics Inc.
Zevra Therapeutics, Inc., a rare disease company melding science, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company is headquartered in Celebration, Florida.
Fundamentals
| Revenue (TTM) | $122.29M |
| Gross Profit (TTM) | $105.25M |
| EBITDA | $12.73M |
| Operating Margin | 24.40% |
| Return on Equity | 100.60% |
| Return on Assets | 2.76% |
| Revenue/Share (TTM) | $2.17 |
| Book Value | $3.48 |
| Price-to-Book | 3.88 |
| Price-to-Sales (TTM) | 6.27 |
| EV/Revenue | 4.895 |
| EV/EBITDA | 4.16 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 77.50% |
| Shares Outstanding | $59.12M |
| Float | $54.96M |
| % Insiders | 1.28% |
| % Institutions | 70.73% |
Historical Volatility
HV 10-Day
105.39%
HV 20-Day
85.91%
HV 30-Day
75.28%
HV 60-Day
61.15%
HV Rank
88.9%
Volatility is currently expanding
Analyst Ratings
Consensus ($27.89 target)
2
Strong Buy7
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026